| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/31/2003 | WO2002020847A3 Gene and sequence variation associated with lipid disorder |
| 07/31/2003 | WO2002019814A3 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety |
| 07/31/2003 | WO2002018444A3 Erbb4 antagonists |
| 07/31/2003 | WO2002012286A3 Stress proteins and peptides and methods of use thereof |
| 07/31/2003 | WO2002006339A3 Proteins and nucleic acids encoding same |
| 07/31/2003 | WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 07/31/2003 | WO2001098348A3 Regulation of cellproliferation and differentiation using topically applied peptides |
| 07/31/2003 | WO2001098339A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/31/2003 | WO2001096870A3 Immunoassays for anti-hcv antibodies |
| 07/31/2003 | WO2001085912A3 Presenilin enhancers |
| 07/31/2003 | WO2001062298A9 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 07/31/2003 | US20030145355 Methods of commercial production and extraction of protein from seed |
| 07/31/2003 | US20030145353 Polynucleotide comprising chimera genes linked to regulatory sequences that code for glycogenin, used for transforming cells and regenerating plants; genetic engineering |
| 07/31/2003 | US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch |
| 07/31/2003 | US20030145345 LexA DNA binding domain optimized for arabidopsis species |
| 07/31/2003 | US20030145344 Gene expression in plants; gene coding matallothionein; genomic library; transformed plant cell |
| 07/31/2003 | US20030145343 Transgenic animals expressing human p25 |
| 07/31/2003 | US20030145342 Activation; transgenic rodent; genetic engineering |
| 07/31/2003 | US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 07/31/2003 | US20030144498 Binding antibody to tyrosine kinase; neovascularization; antitumor agent |
| 07/31/2003 | US20030144494 Using polypeptide; incubation, calibration drug |
| 07/31/2003 | US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents |
| 07/31/2003 | US20030144490 Extended cDNAs for secreted proteins |
| 07/31/2003 | US20030144484 Polynucleotides; immunoassay, immunotherapy |
| 07/31/2003 | US20030144482 Diagnosis of skin cancer; vaccine |
| 07/31/2003 | US20030144481 Controlling angiogenesis; controlling cell differentiation, proliferation |
| 07/31/2003 | US20030144480 Genetic engineering; medical diagnosis |
| 07/31/2003 | US20030144479 Biologically active compounds and methods of constructing and using the same |
| 07/31/2003 | US20030144478 Molecules designated B7L-1 |
| 07/31/2003 | US20030144477 Therapy for autoimmune disease; major histocompatibility complex; side effect reduction; myasthenia gravis |
| 07/31/2003 | US20030144476 Genetic engineered polypeptide; medical diagnosis |
| 07/31/2003 | US20030144475 Human protein and cdna |
| 07/31/2003 | US20030144474 T cell receptor and a biologically active polypeptide with different recognition biding sites connected by a peptide linker; designed to redirect the immune system against various diseases |
| 07/31/2003 | US20030144473 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 07/31/2003 | US20030144472 Method of identifying designable protein backbone configurations |
| 07/31/2003 | US20030144239 Expression system |
| 07/31/2003 | US20030144238 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/31/2003 | US20030144236 Administering an enzyme inhibitor for treating tumor, abnormal cell growth and proliferation |
| 07/31/2003 | US20030144232 Expression system |
| 07/31/2003 | US20030144230 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation |
| 07/31/2003 | US20030144226 Drug screening for an antiviral agent, viricides; genetic engineering |
| 07/31/2003 | US20030144211 Inhibit leukocyte adhesion to endothelium or to platelets |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030144209 Bone anabolic agents for the treatment of bone disease |
| 07/31/2003 | US20030144205 Polynucleotide sequence encoding a polypeptide comprising an amino acid sequence that modulates protein degradation during gametogenesis and early development |
| 07/31/2003 | US20030144201 Use of HMGB fragments as anti-inflammatory agents |
| 07/31/2003 | US20030144200 Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGF |
| 07/31/2003 | US20030144199 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 07/31/2003 | US20030144197 Autologous growth factor cocktail composition, method of production and use |
| 07/31/2003 | US20030144196 Derived from a cDNA subtraction library constructed from human peripheral blood T lymphocytes activated with antibodies against CD3 and CD28 cell surface antigens |
| 07/31/2003 | US20030144195 Therapeutic peptide-based constructs |
| 07/31/2003 | US20030144194 Cancer treatment and prognosis |
| 07/31/2003 | US20030144193 For the prevention or amelioration of symptoms of anthrax; fusion polypeptides |
| 07/31/2003 | US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica) |
| 07/31/2003 | US20030144191 Polynucleotide encoding a novel TRP channel family member, TRP-PLIK2, and splice variants thereof |
| 07/31/2003 | US20030144190 Apoptosis modulation in fast growing cells and induction and/or stimulation of proapoptotic pathway in fast growing cells, especially in Ras-induced malignancies |
| 07/31/2003 | US20030144188 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/31/2003 | US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders |
| 07/31/2003 | US20030144186 Conformationally constrained backbone cyclized peptide analogs |
| 07/31/2003 | US20030144183 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 07/31/2003 | US20030144182 CD40-Ligand lacking native-pattern glycosylation |
| 07/31/2003 | US20030144174 Methods for identifying compounds useful for the regulation of body weight and associated conditions |
| 07/31/2003 | US20030144165 For use in detergents and in baking |
| 07/31/2003 | US20030143760 Diagnosing brain diseases |
| 07/31/2003 | US20030143741 Rolling circle replicon expression vector |
| 07/31/2003 | US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 07/31/2003 | US20030143734 Amino acid transporters and uses |
| 07/31/2003 | US20030143731 Effecting transcription of target genes in genetically engineered cells or organisms containing them |
| 07/31/2003 | US20030143729 Also animal models; use determining substrate binding, detecting expression, drug screening, and treatments for diseases or conditions related to 4-aminobutyric acid (GABA) or taurine transporters |
| 07/31/2003 | US20030143726 Biosensor involving the use of optically sensitive moieties |
| 07/31/2003 | US20030143715 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203 |
| 07/31/2003 | US20030143709 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 07/31/2003 | US20030143707 Proteins having DNA repair promoting activity |
| 07/31/2003 | US20030143706 Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 |
| 07/31/2003 | US20030143705 IovE variant regulator molecules |
| 07/31/2003 | US20030143697 Nucleic acid encoding a fusion polypeptide that forms a multimer that binds to a cytokine to form a nonfunctional complex; cytokine antagonists for the treatment of cytokine-related diseases or disorders |
| 07/31/2003 | US20030143696 Human chemokine beta-13 |
| 07/31/2003 | US20030143695 Novel polypeptide and dna thereof |
| 07/31/2003 | US20030143694 Containing beta-FSH subunit covalently bound to a polypeptide segment having amino acid sequence: ser-gly-ser-asn-ala-thr-gly-ser-gly-ser-asn-ala-thr-ser-gly-se r; useful for fertility, egg production and spermatogenesis |
| 07/31/2003 | US20030143693 Growing, under suitable conditions, procaryotic or eucaryotic host cells transformed or transfected with a specific DNA, and isolating the desired polypeptide product of the expression of such DNA sequence |
| 07/31/2003 | US20030143692 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 07/31/2003 | US20030143691 Human testin |
| 07/31/2003 | US20030143689 Peptides and proteins that effect ligand transport encoded by a specific nucleic acid, useful in development of human therapeutics and diagonstic formulations and procedures |
| 07/31/2003 | US20030143688 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 07/31/2003 | US20030143687 Biologic variability of asthma associated factors useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 07/31/2003 | US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product |
| 07/31/2003 | US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
| 07/31/2003 | US20030143681 Diagnose and treat neurological conditions |
| 07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
| 07/31/2003 | US20030143678 Zlrr3: a human leucine-rich repeat protein |
| 07/31/2003 | US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin |
| 07/31/2003 | US20030143675 Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, 8099, 46455, 54414, 53763, 67076, 67102, 44181, 67084FL, 67084ALT, FBH58295FL, 57255, and 57255alt molecules and uses therefor |
| 07/31/2003 | US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides |
| 07/31/2003 | US20030143673 Barnacle adhesion proteins |
| 07/31/2003 | US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes |
| 07/31/2003 | US20030143671 Anti-microbial polypeptides can be sequence-defined by conserved cysteine residue patterns and are termed defensins; anti-idiotypic antibody of an antibody which specifically binds to above polypeptide or protein |
| 07/31/2003 | US20030143670 Identification of three peptide agonists for the orphan GPCR( G-protein coupled receptor) designated SNORF44 |
| 07/31/2003 | US20030143668 Guanosine triphosphate-binding protein coupled receptors |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |